PP12 Fresh Thoughts on Diabetes Treatment

Program: Abstracts - Orals, Poster Previews, and Posters
Poster Session
Diabetes & Glucose Metabolism-Clinical
Friday, April 1, 2016: 11:30 AM-11:45 AM
Room 210 (BCEC)
Chairs:
Samuel Dagogo-Jack, MD, University of Tennessee, Memphis, TN and To Be Determined

Nothing to Disclose: SD Disclosure Not Provided: LCC, BOY
Mohammed Al-Sofiani, MD, MSc, Internal Medicine Residency Program, University at Buffalo- CHS, Williamsville, NY, Shabnam Rehman, Internal Medicine Department, University at Buffalo-CHS, Buffalo and Howard A Lippes, Endocrinology Division, University at Buffalo-CHS, Williamsville, NY
Poster Board Number: FRI 684
Farid Saad, DVM, PhD1, Ahmad Haider, MD, PhD2, Karim Sultan Haider2, Gheorghe Doros, PhD3 and Abdulmaged M Traish, PhD4, (1)Global Medical Affairs Andrology, Bayer Pharma AG, Berlin, Germany
(2)Private Urology Practice, Bremerhaven, Germany
(3)Department of Epidemiology and Statistics, Boston University School of Public Health, Boston, MA
(4)Boston University School of Medicine, Boston, MA
Poster Board Number: FRI 686
Andrew Orville Paulus, MD1, Jeffrey Adam Colburn, MD1, Jack Edward Lewi, MD2, Irene Folaron, MD1, Sky Denniston Graybill, MD1, Richard Price Davis, MD2, Darrick James Beckman, MD1 and Mark Windell True, MD2, (1)San Antonio Military Medical Center, San Antonio, TX
(2)Department of Medicine, Endocrinology Service, San Antonio Military Medical Center, San Antonio, TX
Poster Board Number: FRI 683
Maria Burnett, MD1, H. Omer Ikizler, BA1, Annis Morison Marney, MD2 and Matthew P. Gilbert, DO, MPH3, (1)The University of Vermont College of Medicine
(2)Frist Clinic
(3)Division of Endocrinology and Diabetes, The University of Vermont College of Medicine, South Burlington, VT
Poster Board Number: FRI 688

 

The Endocrine Society would like to thank the following organizations for their support: AbbVie Inc.; Bayer HealthCare Pharmaceuticals Inc.; Boehringer Ingelheim Pharmaceuticals, Inc.; Chiasma, Inc.; Corcept Therapeutics Incorporated; Eisai, Inc.; Ethicon Endo-Surgery, Inc.; Genzyme, a Sanofi company, Ipsen Biopharmaceuticals, Inc.; Leona M. and Harry B. Helmsley Charitable Trust; Lilly USA, LLC; Medtronic Diabetes; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; Novo Nordisk Inc.; Pfizer, Inc.; Shire